# ASCO Guidelines vs HemOncBytes

The clearest difference is review sentiment: HemOncBytes at 100% against ASCO Guidelines's 57%. HemOncBytes also leads on rating (5.0 vs 4.8) and update cadence (every 2 months vs every 5 months). ASCO Guidelines's advantage is in-app purchases (none vs 1) and ratings volume (257 vs 7). On price, ads and device support there is nothing between them.

Both are free to download. HemOncBytes sells 1 one-off in-app purchase. ASCO Guidelines asks for nothing beyond the download.

HemOncBytes holds the better App Store score, 5.0 against 4.8. That said, the two scores are not equally well evidenced: ASCO Guidelines has 257 ratings behind it against 7, so its average is the more settled of the two. Written reviews point the same way: 57% of ASCO Guidelines's written reviews are positive against 100% of HemOncBytes's.

ASCO Guidelines ships an update every 5 months, HemOncBytes every 2 months. The most recent releases landed on October 8, 2026 and October 7, 2026 respectively.

## The numbers

| Metric | ASCO Guidelines | HemOncBytes |
| --- | --- | --- |
| Price | Free | Free |
| Rating | [4.8 (257 ratings)](https://appshunter.io/ios/app/asco-guidelines/id1238827183/reviews) | **[5.0 (7 ratings)](https://appshunter.io/ios/app/hemoncbytes/id6749437597/reviews)** |
| Number of ratings | **257** | 7 |
| Positive reviews | 57.1% of reviews | **100.0% of reviews** |
| In-app purchases | **No** | Yes |
| Ads | No | No |
| Update frequency | Every 5 months | **Every 2 months** |
| Monetization | **Free** | Free with in-app purchases |
| Size | 411 MB | 111 MB |
| Requires iOS | **10.0** | 15.2 |
| Devices | iPhone, iPad, iPod | iPhone, iPad, iPod |
| Age rating | 12+ | 4+ |
| Developer | [American Society of Clinical Oncology](https://appshunter.io/developer/1513043539) | [VitalFolio LLC](https://appshunter.io/developer/1830427949) |

## What reviewers say

### ASCO Guidelines

[App page](https://appshunter.io/ios/app/asco-guidelines/id1238827183)

Access comprehensive cancer care guidelines and interactive tools to inform treatment decisions. This app supports healthcare providers, patients, and caregivers in implementing recommended cancer care options for various cancer types, aiming to improve the quality of care.

**Highlights:** Guideline recommendations for cancer care, Interactive treatment decision tools, Supports healthcare providers, Informs patients and caregivers, Covers various cancer types, Regularly updated content

**Features:** macOS Compatibility, Vision Pro support

**In-app purchases:** none


### HemOncBytes

[App page](https://appshunter.io/ios/app/hemoncbytes/id6749437597)

Stay current with hematology and oncology information through concise, actionable updates. This app uses a microlearning and active recall method to boost clinical confidence and decision-making speed. Content is clinically relevant and vetted by practicing oncologists.

**Highlights:** Quick, actionable bytes of information, Microlearning and active recall, Clinically relevant content, Vetted by practicing oncologists, Boosts clinical confidence, Practice-changing updates

**Features:** macOS Compatibility, Vision Pro support

**In-app purchases (1)**

| Purchase | Price | Billing |
| --- | --- | --- |
| Best of ASCO 2025 | $100.00 | one-time |


## Frequently asked questions

### Is ASCO Guidelines free?

ASCO Guidelines is free to download, with no in-app purchases.

### Is HemOncBytes free?

HemOncBytes is free to download, with in-app purchases available.

### Which has better reviews, ASCO Guidelines or HemOncBytes?

HemOncBytes is rated higher. ASCO Guidelines averages 4.8 out of 5 from 257 ratings, while HemOncBytes averages 5.0 from 7 ratings.

### Do ASCO Guidelines or HemOncBytes have ads?

Neither ASCO Guidelines nor HemOncBytes shows ads.

### Which is updated more often, ASCO Guidelines or HemOncBytes?

ASCO Guidelines ships an update every 5 months, and HemOncBytes every 2 months. Most recently, ASCO Guidelines was updated on October 8, 2026 and HemOncBytes on October 7, 2026.

---

*Compared by [AppsHunter](https://appshunter.io/) from daily US App Store data. Review summaries are generated from verbatim App Store reviews.*